Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase.
作者信息
Xu Zheng, Cai Lu
机构信息
Cardiovascular Center at the First Hospital of Jilin University, Changchun, China.
Cardiovascular Center at the First Hospital of Jilin University, Changchun, China.
出版信息
J Mol Cell Cardiol. 2015 Jul;84:10-2. doi: 10.1016/j.yjmcc.2015.04.002. Epub 2015 Apr 10.
Abstract
摘要
相似文献
1
Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase.糖尿病性心肌病：表皮生长因子受体酪氨酸激酶的作用
J Mol Cell Cardiol. 2015 Jul;84:10-2. doi: 10.1016/j.yjmcc.2015.04.002. Epub 2015 Apr 10.
2
EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.表皮生长因子受体抑制通过减轻 STZ 诱导的糖尿病小鼠模型中的氧化应激来保护心脏损伤和重构。
J Mol Cell Cardiol. 2015 May;82:63-74. doi: 10.1016/j.yjmcc.2015.02.029. Epub 2015 Mar 7.
3
Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.载脂蛋白对糖尿病自发性高血压大鼠氧化应激和心脏重塑的影响。
Cardiovasc Diabetol. 2016 Sep 1;15(1):126. doi: 10.1186/s12933-016-0442-1.
4
Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.富马酸二甲酯对1型糖尿病小鼠糖尿病性心肌病的保护作用可能是通过激活核因子红细胞2相关因子2实现的。
Toxicol Lett. 2018 May 1;287:131-141. doi: 10.1016/j.toxlet.2018.01.020. Epub 2018 Feb 3.
5
Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.芦丁可缓解糖尿病心肌病，并改善糖尿病载脂蛋白 E 基因敲除小鼠的心脏功能。
Eur J Pharmacol. 2017 Nov 5;814:151-160. doi: 10.1016/j.ejphar.2017.08.023. Epub 2017 Aug 19.
6
Novel protective role of the circadian nuclear receptor retinoic acid-related orphan receptor-α in diabetic cardiomyopathy.昼夜节律核受体视黄酸相关孤儿受体-α在糖尿病心肌病中的新保护作用。
J Pineal Res. 2017 Apr;62(3). doi: 10.1111/jpi.12378. Epub 2017 Feb 22.
7
N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.N-乙酰半胱氨酸消除了氯沙坦对心肌病仓鼠左心室重塑的保护作用。
Antioxid Redox Signal. 2008 Dec;10(12):1999-2008. doi: 10.1089/ars.2008.2069.
8
Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.替米沙坦通过过氧化物酶体增殖物激活受体δ（PPARδ）改善糖尿病患者的心脏纤维化：从临床到实验台研究
Cardiovasc Diabetol. 2016 Aug 12;15(1):113. doi: 10.1186/s12933-016-0430-5.
9
Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.非诺贝特通过成纤维细胞生长因子21/沉默信息调节因子1增加心脏自噬，并预防1型糖尿病小鼠心脏的纤维化和炎症。
Clin Sci (Lond). 2016 Apr;130(8):625-41. doi: 10.1042/CS20150623. Epub 2016 Jan 21.
10
Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.miRNAs 下调与氧化应激增加在糖尿病性心功能障碍发展中的关系：连接蛋白 junctin 作为 miR-1 的靶蛋白。
Cell Biochem Biophys. 2013;67(3):1397-408. doi: 10.1007/s12013-013-9672-y.
引用本文的文献
1
The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications.受体酪氨酸激酶表皮生长因子受体家族在介导糖尿病诱发的心血管并发症中的作用
Front Pharmacol. 2021 Aug 2;12:701390. doi: 10.3389/fphar.2021.701390. eCollection 2021.
2
The Role of iRhom2 in Metabolic and Cardiovascular-Related Disorders.iRhom2在代谢及心血管相关疾病中的作用
Front Cardiovasc Med. 2020 Nov 24;7:612808. doi: 10.3389/fcvm.2020.612808. eCollection 2020.
本文引用的文献
1
EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.表皮生长因子受体抑制通过减轻 STZ 诱导的糖尿病小鼠模型中的氧化应激来保护心脏损伤和重构。
J Mol Cell Cardiol. 2015 May;82:63-74. doi: 10.1016/j.yjmcc.2015.02.029. Epub 2015 Mar 7.
2
Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy.表皮生长因子受体抑制作用可减缓糖尿病肾病的进展，同时伴随着内质网应激的减少和自噬的增加。
Diabetes. 2014 Jun;63(6):2063-72. doi: 10.2337/db13-1279. Epub 2014 Apr 4.
3
Targeting the epidermal growth factor receptor in solid tumors: focus on safety.针对实体瘤中的表皮生长因子受体：聚焦安全性。
Expert Opin Drug Saf. 2014 May;13(5):535-49. doi: 10.1517/14740338.2014.904283. Epub 2014 Apr 1.
4
Molecular mechanisms of diabetic cardiomyopathy.糖尿病心肌病的分子机制。
Diabetologia. 2014 Apr;57(4):660-71. doi: 10.1007/s00125-014-3171-6. Epub 2014 Jan 30.
5
Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.糖尿病心肌病：抗氧化信号通路为靶点的发病机制和新治疗策略。
Pharmacol Ther. 2014 Jun;142(3):375-415. doi: 10.1016/j.pharmthera.2014.01.003. Epub 2014 Jan 22.
6
Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.通过Rho激酶和ERK1/2激活ErbB2及下游信号传导，导致糖尿病诱导的血管功能障碍。
PLoS One. 2013 Jun 27;8(6):e67813. doi: 10.1371/journal.pone.0067813. Print 2013.
7
EGFR and the complexity of receptor crosstalk in the cardiovascular system.EGFR 与心血管系统中受体串扰的复杂性。
Curr Mol Med. 2013 Jan;13(1):3-12.
8
Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury.通过涉及 ERK1/2、P38MAPK、AKT 和 FOXO 的途径激活 EGFR/ERBB2 可增强糖尿病心脏对缺血再灌注损伤的恢复。
PLoS One. 2012;7(6):e39066. doi: 10.1371/journal.pone.0039066. Epub 2012 Jun 13.
9
A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.表皮生长因子受体酪氨酸激酶及其下游内质网应激在 1 型糖尿病心脏损伤和微血管功能障碍中的新作用。
Hypertension. 2012 Jul;60(1):71-80. doi: 10.1161/HYPERTENSIONAHA.112.192500. Epub 2012 Jun 4.
10
Therapeutic targeting of the epidermal growth factor receptor in human cancer.人类癌症中表皮生长因子受体的治疗靶向作用。
Crit Rev Oncog. 2012;17(1):31-50. doi: 10.1615/critrevoncog.v17.i1.40.
Zotero 插件